Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VEGF
Pharma
Merck CMO talks Akeso, Summit's Keytruda head-to-head win
Ivonescimab's head-to-head win against Keytruda in a China phase 3 NSCLC trial has drawn much interest on the sidelines of the ASCO meeting.
Angus Liu
Jun 3, 2024 12:00pm
Summit and Akeso deliver Keytruda-topping results in NSCLC
May 31, 2024 11:00am
Novartis targets longer Beovu dosing interval in DME
Aug 17, 2021 10:15am
Novartis caps 3 Beovu trials on safety concerns
Jun 1, 2021 11:41am
Novartis hits setback in bid to block Eylea prefilled syringe
May 4, 2021 9:55am
Regeneron shoots for longer Eylea dosing interval with NIH data
Apr 2, 2021 8:04am
